PRE vs. FHLT, CERO, ARYD, MLSS, CLNN, CTSO, OCUP, NSPR, LUCD, and AADI
Should you be buying Prenetics Global stock or one of its competitors? The main competitors of Prenetics Global include Future Health ESG (FHLT), CERo Therapeutics (CERO), ARYA Sciences Acquisition Corp IV (ARYD), Milestone Scientific (MLSS), Clene (CLNN), Cytosorbents (CTSO), Ocuphire Pharma (OCUP), InspireMD (NSPR), Lucid Diagnostics (LUCD), and Aadi Bioscience (AADI). These companies are all part of the "medical" sector.
Future Health ESG (NASDAQ:FHLT) and Prenetics Global (NASDAQ:PRE) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations, community ranking and profitability.
Prenetics Global has a consensus target price of $9.00, indicating a potential upside of 55.07%. Given Future Health ESG's higher possible upside, analysts plainly believe Prenetics Global is more favorable than Future Health ESG.
Future Health ESG has higher earnings, but lower revenue than Prenetics Global.
Prenetics Global received 5 more outperform votes than Future Health ESG when rated by MarketBeat users.
24.6% of Future Health ESG shares are held by institutional investors. Comparatively, 25.0% of Prenetics Global shares are held by institutional investors. 57.2% of Future Health ESG shares are held by insiders. Comparatively, 7.8% of Prenetics Global shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Future Health ESG has a net margin of 0.00% compared to Future Health ESG's net margin of -193.60%. Prenetics Global's return on equity of -9.79% beat Future Health ESG's return on equity.
Future Health ESG has a beta of -0.12, suggesting that its stock price is 112% less volatile than the S&P 500. Comparatively, Prenetics Global has a beta of -0.28, suggesting that its stock price is 128% less volatile than the S&P 500.
In the previous week, Future Health ESG had 1 more articles in the media than Prenetics Global. MarketBeat recorded 3 mentions for Future Health ESG and 2 mentions for Prenetics Global. Prenetics Global's average media sentiment score of 1.17 beat Future Health ESG's score of 0.29 indicating that Future Health ESG is being referred to more favorably in the media.
Summary
Future Health ESG beats Prenetics Global on 8 of the 13 factors compared between the two stocks.
Get Prenetics Global News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Prenetics Global Competitors List
Related Companies and Tools
